Role of Rho-kinase and p27 in angiotensin II-induced vascular injury

Takeshi Kanda, Koichi Hayashi, Shu Wakino, Koichiro Honma, Kyoko Yoshioka, Kazuhiro Hasegawa, Naoki Sugano, Satoru Tatematsu, Ichiro Takamatsu, Takayuki Mitsuhashi, Takao Saruta

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Angiotensin II enhances the development of atherosclerotic lesion in which cellular proliferation and/or migration are critical steps. Although cyclin-dependent kinase inhibitor, p27, and Rho/Rho-kinase pathway have recently been implicated as factors regulating these events cooperatively, their role in vivo has not been fully elucidated. We evaluated the contribution of p27 and Rho-kinase to angiotensin II-induced vascular injury using p27-deficient mice. Two-week angiotensin II (1500 ng/kg per minute SC) infusion elicited similar degrees of elevation in systolic blood pressure in wild-type mice (159±5 mm Hg) and p27-deficient mice (157±5 mm Hg; P>0.05). Angiotensin II infusion to wild-type mice resulted in increases in the medial thickness of aorta, proliferating cell number, and monocyte/macrophage infiltration within the vasculature. In p27-deficient mice, however, these changes were more prominent than those in wild-type mice. Treatment of wild-type mice with fasudil, a selective Rho-kinase inhibitor, did not alter blood pressure but significantly upregulated p27 expression, decreased medial thickness of aorta, reduced proliferating cell number, and prevented monocyte/macrophage infiltration. These protective effects of fasudil were attenuated in p27-deficient mice. In conclusion, p27 constitutes an important modulator of angiotensin II-induced monocyte/macrophage infiltration and vascular remodeling, which is mediated in part by Rho-kinase stimulation. Inhibition of Rho-kinase activity improves angiotensin II-induced vascular injury through p27-dependent and p27-independent mechanisms.

Original languageEnglish
Pages (from-to)724-729
Number of pages6
JournalHypertension
Volume45
Issue number4 SUPPL.
DOIs
Publication statusPublished - 2005 Apr

Fingerprint

rho-Associated Kinases
Vascular System Injuries
Angiotensin II
Monocytes
Macrophages
Blood Pressure
Aorta
Cell Count
Cyclin-Dependent Kinase Inhibitor p27
Cell Proliferation

Keywords

  • Angiotensin II
  • Hypertension, experimental
  • Macrophages
  • Muscle, smooth, vascular
  • Remodeling

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. / Kanda, Takeshi; Hayashi, Koichi; Wakino, Shu; Honma, Koichiro; Yoshioka, Kyoko; Hasegawa, Kazuhiro; Sugano, Naoki; Tatematsu, Satoru; Takamatsu, Ichiro; Mitsuhashi, Takayuki; Saruta, Takao.

In: Hypertension, Vol. 45, No. 4 SUPPL., 04.2005, p. 724-729.

Research output: Contribution to journalArticle

Kanda, T, Hayashi, K, Wakino, S, Honma, K, Yoshioka, K, Hasegawa, K, Sugano, N, Tatematsu, S, Takamatsu, I, Mitsuhashi, T & Saruta, T 2005, 'Role of Rho-kinase and p27 in angiotensin II-induced vascular injury', Hypertension, vol. 45, no. 4 SUPPL., pp. 724-729. https://doi.org/10.1161/01.HYP.0000153316.59262.79
Kanda, Takeshi ; Hayashi, Koichi ; Wakino, Shu ; Honma, Koichiro ; Yoshioka, Kyoko ; Hasegawa, Kazuhiro ; Sugano, Naoki ; Tatematsu, Satoru ; Takamatsu, Ichiro ; Mitsuhashi, Takayuki ; Saruta, Takao. / Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. In: Hypertension. 2005 ; Vol. 45, No. 4 SUPPL. pp. 724-729.
@article{8f2e3192b29a4837ac09b989297f2ed2,
title = "Role of Rho-kinase and p27 in angiotensin II-induced vascular injury",
abstract = "Angiotensin II enhances the development of atherosclerotic lesion in which cellular proliferation and/or migration are critical steps. Although cyclin-dependent kinase inhibitor, p27, and Rho/Rho-kinase pathway have recently been implicated as factors regulating these events cooperatively, their role in vivo has not been fully elucidated. We evaluated the contribution of p27 and Rho-kinase to angiotensin II-induced vascular injury using p27-deficient mice. Two-week angiotensin II (1500 ng/kg per minute SC) infusion elicited similar degrees of elevation in systolic blood pressure in wild-type mice (159±5 mm Hg) and p27-deficient mice (157±5 mm Hg; P>0.05). Angiotensin II infusion to wild-type mice resulted in increases in the medial thickness of aorta, proliferating cell number, and monocyte/macrophage infiltration within the vasculature. In p27-deficient mice, however, these changes were more prominent than those in wild-type mice. Treatment of wild-type mice with fasudil, a selective Rho-kinase inhibitor, did not alter blood pressure but significantly upregulated p27 expression, decreased medial thickness of aorta, reduced proliferating cell number, and prevented monocyte/macrophage infiltration. These protective effects of fasudil were attenuated in p27-deficient mice. In conclusion, p27 constitutes an important modulator of angiotensin II-induced monocyte/macrophage infiltration and vascular remodeling, which is mediated in part by Rho-kinase stimulation. Inhibition of Rho-kinase activity improves angiotensin II-induced vascular injury through p27-dependent and p27-independent mechanisms.",
keywords = "Angiotensin II, Hypertension, experimental, Macrophages, Muscle, smooth, vascular, Remodeling",
author = "Takeshi Kanda and Koichi Hayashi and Shu Wakino and Koichiro Honma and Kyoko Yoshioka and Kazuhiro Hasegawa and Naoki Sugano and Satoru Tatematsu and Ichiro Takamatsu and Takayuki Mitsuhashi and Takao Saruta",
year = "2005",
month = "4",
doi = "10.1161/01.HYP.0000153316.59262.79",
language = "English",
volume = "45",
pages = "724--729",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Role of Rho-kinase and p27 in angiotensin II-induced vascular injury

AU - Kanda, Takeshi

AU - Hayashi, Koichi

AU - Wakino, Shu

AU - Honma, Koichiro

AU - Yoshioka, Kyoko

AU - Hasegawa, Kazuhiro

AU - Sugano, Naoki

AU - Tatematsu, Satoru

AU - Takamatsu, Ichiro

AU - Mitsuhashi, Takayuki

AU - Saruta, Takao

PY - 2005/4

Y1 - 2005/4

N2 - Angiotensin II enhances the development of atherosclerotic lesion in which cellular proliferation and/or migration are critical steps. Although cyclin-dependent kinase inhibitor, p27, and Rho/Rho-kinase pathway have recently been implicated as factors regulating these events cooperatively, their role in vivo has not been fully elucidated. We evaluated the contribution of p27 and Rho-kinase to angiotensin II-induced vascular injury using p27-deficient mice. Two-week angiotensin II (1500 ng/kg per minute SC) infusion elicited similar degrees of elevation in systolic blood pressure in wild-type mice (159±5 mm Hg) and p27-deficient mice (157±5 mm Hg; P>0.05). Angiotensin II infusion to wild-type mice resulted in increases in the medial thickness of aorta, proliferating cell number, and monocyte/macrophage infiltration within the vasculature. In p27-deficient mice, however, these changes were more prominent than those in wild-type mice. Treatment of wild-type mice with fasudil, a selective Rho-kinase inhibitor, did not alter blood pressure but significantly upregulated p27 expression, decreased medial thickness of aorta, reduced proliferating cell number, and prevented monocyte/macrophage infiltration. These protective effects of fasudil were attenuated in p27-deficient mice. In conclusion, p27 constitutes an important modulator of angiotensin II-induced monocyte/macrophage infiltration and vascular remodeling, which is mediated in part by Rho-kinase stimulation. Inhibition of Rho-kinase activity improves angiotensin II-induced vascular injury through p27-dependent and p27-independent mechanisms.

AB - Angiotensin II enhances the development of atherosclerotic lesion in which cellular proliferation and/or migration are critical steps. Although cyclin-dependent kinase inhibitor, p27, and Rho/Rho-kinase pathway have recently been implicated as factors regulating these events cooperatively, their role in vivo has not been fully elucidated. We evaluated the contribution of p27 and Rho-kinase to angiotensin II-induced vascular injury using p27-deficient mice. Two-week angiotensin II (1500 ng/kg per minute SC) infusion elicited similar degrees of elevation in systolic blood pressure in wild-type mice (159±5 mm Hg) and p27-deficient mice (157±5 mm Hg; P>0.05). Angiotensin II infusion to wild-type mice resulted in increases in the medial thickness of aorta, proliferating cell number, and monocyte/macrophage infiltration within the vasculature. In p27-deficient mice, however, these changes were more prominent than those in wild-type mice. Treatment of wild-type mice with fasudil, a selective Rho-kinase inhibitor, did not alter blood pressure but significantly upregulated p27 expression, decreased medial thickness of aorta, reduced proliferating cell number, and prevented monocyte/macrophage infiltration. These protective effects of fasudil were attenuated in p27-deficient mice. In conclusion, p27 constitutes an important modulator of angiotensin II-induced monocyte/macrophage infiltration and vascular remodeling, which is mediated in part by Rho-kinase stimulation. Inhibition of Rho-kinase activity improves angiotensin II-induced vascular injury through p27-dependent and p27-independent mechanisms.

KW - Angiotensin II

KW - Hypertension, experimental

KW - Macrophages

KW - Muscle, smooth, vascular

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=20144366571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144366571&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000153316.59262.79

DO - 10.1161/01.HYP.0000153316.59262.79

M3 - Article

VL - 45

SP - 724

EP - 729

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4 SUPPL.

ER -